Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Disclosure statements are available on the authors' profiles:
Biomarker Analyses in the Phase 3 ASCENT Study of Sacituzumab Govitecan Versus Chemotherapy in Patients With Metastatic Triple-Negative Breast CancerAnn. Oncol 2021 Jun 08;[EPub Ahead of Print], A Bardia, SM Tolaney, K Punie, D Loirat, M Oliveira, K Kalinsky, A Zelnak, P Aftimos, F Dalenc, S Sardesai, E Hamilton, P Sharma, S Recalde, EC Gil, T Traina, J O'Shaughnessy, J Cortes, M Tsai, L Vahdat, V Diéras, LA Carey, HS Rugo, DM Goldenberg, Q Hong, M Olivo, LM Itri, SA Hurvitz
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.